Invention Grant
- Patent Title: Multi-epitopic construct
-
Application No.: US15546858Application Date: 2016-01-25
-
Publication No.: US11332515B2Publication Date: 2022-05-17
- Inventor: Vijay Kakkar , Xinjie Lu
- Applicant: THROMBOSIS RESEARCH INSTITUTE , Lord Kakkar
- Applicant Address: GB London; GB London
- Assignee: THROMBOSIS RESEARCH INSTITUTE,Lord Kakkar
- Current Assignee: THROMBOSIS RESEARCH INSTITUTE,Lord Kakkar
- Current Assignee Address: GB London; GB London
- Agency: Stinson LLP
- Priority: GB1501354 20150127,GB1510195 20150611
- International Application: PCT/GB2016/050150 WO 20160125
- International Announcement: WO2016/120596 WO 20160804
- Main IPC: C07K14/775
- IPC: C07K14/775 ; A61K39/00 ; A61K39/118 ; C07K14/195 ; C07K14/35 ; C07K14/295 ; C07K14/47 ; C07K14/705

Abstract:
The invention relates to multiple epitope constructs, immunogenic and vaccine compositions comprising recombinant molecules presenting inserted multiple and different epitopes from a variety of antigens. The antigenic determinants being associated with different pathways leading to atherosclerosis. In particular, the invention relates to such compositions for eliciting an immune response against antigens and pathogens involved in the development of atherosclerosis the invention includes inter alia methods of treating and/or preventing the disease and recombinant protein products.
Public/Granted literature
- US20180273608A1 MULTI-EPITOPIC CONSTRUCT Public/Granted day:2018-09-27
Information query